Elanco Animal Health Incorporated, commonly known as Elanco, is a leading global animal health company headquartered in the United States. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of products and services, including pharmaceuticals, vaccines, and nutritional products. Elanco's commitment to improving animal health and welfare is evident in its unique offerings, which are designed to enhance productivity and sustainability in animal agriculture. The company has achieved notable milestones, including the launch of several groundbreaking products that address critical health challenges in animals. As a trusted partner in the animal health sector, Elanco continues to strengthen its market position through research and development, ensuring a healthier future for animals and the people who care for them.
How does Elanco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Elanco's score of 62 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Elanco reported total greenhouse gas emissions of approximately 175,807,000 kg CO2e for Scope 1, 302,607,000 kg CO2e for Scope 2 (market-based), and 496,505,000 kg CO2e for Scope 3 emissions. This represents a significant increase in emissions compared to 2023, where Scope 1 emissions were about 145,021,000 kg CO2e, Scope 2 emissions (market-based) were approximately 285,188,000 kg CO2e, and Scope 3 emissions totalled around 655,353,000 kg CO2e. Elanco has set ambitious climate commitments, aiming for net zero Scope 1 and 2 greenhouse gas emissions for its Hook office by 2030. Additionally, the company is committed to helping its customers avoid approximately 21 million metric tons of GHG emissions by 2030, using 2020 as the baseline year. This commitment is part of a broader strategy to purchase renewable electricity equal to 100% of its electricity consumption by 2030. Elanco's long-term targets include a commitment to net zero emissions across all scopes by 2050, as recognised by the Science Based Targets initiative (SBTi). The company is actively working towards these goals, with specific initiatives in place to reduce emissions from its operations and supply chain.
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elanco has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Elanco's sustainability data and climate commitments